Cohort: Cohort 6, 2021
Focus in insurance value chain/workflow: Point of underwriting
Specific lines of business supported: Personal
Founded: 2019
Status: Operating, still in insurance
Company type: MGA
Head office: United Kingdom
Main global offices: United Kingdom
Locations served: United Kingdom, USA
Employee count: 11-100
Gaia has created an IVF (in vitro fertilisation) insurance product that predicts fertility outcomes and insures against the risk of failure. The product is an embedded insurance, financing, and payment solution integrated into UK fertility clinics with customers paying off the treatment when they have a child. Patients build and choose insurance coverage at the point of sale, online. The company also offers members access to qualified medical and counselling support.
Primary focus product area whilst in the Accelerator: Fertility
Gaia developed its IVF insurance product whilst in the Accelerator. During the Lab, Gaia updated its existing model, which could then be used to predict the change of success during IVF, to also suggest how many cycles may be needed to achieve pregnancy. Gaia met its current capacity providers, Chaucer and Beazley, through the Lab and continues to work closely with them.
“The Accelerator helped us in two ways. It gave us access to a large group of people in a structured format to test our product. It also allowed us to work in a cohort with people that were serious about considering alternative products, distribution channels and capacity.”Nader AlSalim, Founder and Chief Executive Officer
Learn about all our alumni who have take part in the Lloyd’s Lab Accelerator programme.
Gaia website 
Explore all our alumni